He concluded: ‘The big implication of this study a limit on the to put a limit on the duration of antibiotic therapy for CAP, similar to the ventilator-associated pneumonia needless prolonging the duration of antimicrobial treatment is rather select for antibiotic resistance täällä . Or, even worse, instead of false hope in a failing therapy if ongoing infection is the cause really. The greatest clinical benefit of procalcitonin-directed therapy still seems the selection of patients take take antibiotics at all or at least not be a beta-lactam antibiotics . G. Wunderink, Feinberg School of Medicine Northwestern University, 676 North St. In Chicago,Letters To USA Today article Respond On High Price of new cancer drugsTwo letters to the editor of USA Today on Tuesday responded to an article published on 11 Published in July, examined how the high prices of new cancer drugs – as much as $ 10,000 per month for a treatment for patients for patients and health insurance companies have raised. Summaries of the letters appear below. Robert Goldberg: The article explains that ‘because most new drugs are not ”do cancer in most patients, they should not be so expensive ‘healing Goldberg, vice president of the Center for Science in the Public Interest writes. According to according to Goldberg, new cancer drugs ‘increased the life expectancy of people with cancer about a year diagnosed ‘between 1975 and 1995, and the mortality rate from this disease has decreased faster since 1995 than at any other time, according to Goldberg. That the article on that the article on ‘studies that proven medications for specific groups from the results of of one-size-fits-all studies have proven ‘instead of studies that focus ‘matched the right drug to the right patient, long before the disease progresses. ‘Goldberg concludes, ‘USA Today to shell out money to shell out money for cancer drugs questioned. Question of why question of why health plans the entire cost of the entire cost of cheaper and less effective drugs but have Avastin ‘(Goldberg, USA Today.
Cervical cancer and HPV infection is in the EUcervical cancer is the second most common cancer following breast cancer of women aged 15-44 olds in the EU. Each year there are some 33 000 cervical cancers in the EU, and 15 000 deaths. The primary cause of of cervical has a persisting infection the reproductive tract by a high-risk HPV type.